Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Rhode Island Blood Center, A Division of New York Blood Center, Inc.
FDA Inspection
•Rhode Island Blood Center, A Division of New York Blood Center, Inc.•August 20, 2014

Rhode Island Blood Center, A Division of New York Blood Center, Inc. – FDA Inspection, Aug 20, 2014

Record Details

This FDA Inspection record concerns Rhode Island Blood Center, A Division of New York Blood Center, Inc., with an inspection on August 20, 2014, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company
Rhode Island Blood Center, A Division of New York Blood Center, Inc.
Inspection Date
August 20, 2014
Product Type
Biologics
Office
Center for Biologics Evaluation and Research
View Company Profile

ID · c4cd664f-7d1a-459a-9cbc-890a9e50c7bb

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
891892
FDA center
Biologics
Project area
Blood and Blood Products

FDA Citations

5
  1. 21 CFR 600.14(c)When to report
  2. 21 CFR 606.160(b)Required records
  3. 21 CFR 606.160(a)(1)Concurrent documentation
  4. 21 CFR 606.160(a)(1)Person performing, test results, interpretation
  5. 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Rhode Island Blood Center, A Division of New York Blood Center, Inc.

8
DateClassificationOfficeProject area
August 1, 2025NAINew England District OfficeHuman Cellular, Tissue, and Gene Therapies
March 7, 2023NAICenter for Biologics Evaluation and ResearchVaccines and Allergenic Products
July 26, 2019NAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
September 14, 2017Not classifiedNew England District Office
November 7, 2016NAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
View all 8 other inspections on the company page
Other documents for Rhode Island Blood Center, A Division of New York Blood Center, Inc.
  • FDA Inspection 1277157 - 2025-08-01
  • FDA Inspection 1201246 - 2023-03-07
  • FDA Inspection 1106753 - 2019-07-26
  • FDA Inspection 1025554 - 2017-09-14
  • FDA Inspection 995774 - 2016-11-07

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Rhode Island Blood Center, A Division of New York Blood Center, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.